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The effects of a monetary reward and self-monitoring on reducing interdialytic
weight gain (IWG) were compared for 6 hemodialysis patients in an outpatient setting. A
single-subject experimental design (A-B-BC-B-BC) was used to examine each variable
individually and in combination, with alternating phases to control for possible
sequencing effects. Monetary reward (50 cents - $3) was administered in a titrated
manner according to standardized criteria, ranging from 3 % and 4% of patients’ dry
weight on weekdays and weekends, respectively, to 3.5% and 4.5% for weekdays and
weekends. Self-monitoring involved recording daily fluid and diet intake.
Results indicated that by the end of the treatment program, the 6 participants
averaged a 14% reduction in weekday IWG and a 15.45% reduction in weekend IWG;
however, due to significant variability, it cannot be concluded that the reductions are
treatment effects. Four out of 6 participants reduced their average IWG for both
weekends and weekdays by .75 kg (1.65 lb.). The average weekend reduction for these 4
participants was .85 kg (1.87 lbs.) while the average weekday reduction was .65 kg (1.43
lb.). All 6 participants showed reductions in weekday IWG that averaged .53 kg (1.17
lb.). However, only 2 participants demonstrated IWG reductions that could be attributable
to either of the 2 treatment variables. The standardized dry weight criterion for assessing
fluid adherence may have posed excessively stringent demands on participants, as only 1
of the 6 participants actually met the criterion. Future research should address the role of
nonspecific treatment factors, as well as patient characteristics and responsivity to
particular treatment components in an effort to identify those factors responsible for
behavior change in this population.
ii
ACKNOWLEDGEMENTS
Gratitude is extended to all of the hemodialysis patients who gave their time and
energy to participating in this research. I would like to thank my committee for their time
and feedback.  I want to especially thank Dr. Janet Ellis for assisting with funding for this





LIST OF TABLES AND FIGURES............................................................................... iv
INTRODUCTION........................................................................................................... 5











Standardized dry weight criterion
DISCUSSION ................................................................................................................. 40




LIST OF TABLES AND FIGURES
TABLE 1
Comparisons of weekend and weekday average interdialytic weight gain
(IWG) between baseline phase and final treatment phase………………………….48
TABLE 2
Descriptive statistics of interdialytic weight gain (IWG) for baseline and
treatment phases of participants in each condition………………………………….49
TABLE 3
Percent change statistics of mean interdialytic weight gain (IWG) per phase……...50
FIGURE 1
Participant 1’s weekend and weekday gains since previous dialysis session……….51
FIGURE 2
Participant 2’s weekend and weekday gains since previous dialysis session……….52
FIGURE 3
Participant 3’s weekend and weekday gains since previous dialysis session……….53
FIGURE 4
Participant 4’s weekend and weekday gains since previous dialysis session……….54
FIGURE 5
Participant 5’s weekend and weekday gains since previous dialysis session……….55
FIGURE 6
Participant 6’s weekend and weekday gains since previous dialysis session……….56
5
Over 300,000 people in the United States suffer from end-stage renal disease, a
condition that is most often caused by diabetes, hypertension, and glomerulonephritis
(ESRD; U. S. Renal Data System 1997 annual data). An ESRD diagnosis is made when
an individual loses approximately 85 % to 90% of kidney function. Due to the failure of
the kidneys to remove wastes and toxins from the blood, over 60% of these ESRD
patients must depend upon hemodialysis (HD) for their survival. Treatment for ESRD is
demanding and involves HD sessions three times per week, typically 4 hours per session.
Although kidney transplants may prolong the lives of these patients, over 50,000 people
died from ESRD in 1995 (U. S. Renal Data System 1997 annual data report).
In addition to thrice weekly dialysis sessions, HD patients must restrict the
amount of fluids consumed on a daily basis. Due to the kidneys' failure to regulate the
levels of phosphorus and potassium in the body, patients must also avoid foods high in
potassium and take phosphorus-binding medications. Therefore, a patient’s treatment
effectiveness is greatly dependent upon his or her self-management skills. Research has
shown that from 60% to 80% of patients died as a direct consequence of excessive fluid
intake and eating foods that were against the prescribed treatment regimen (Abram,
Moore, & Westervelt, 1971; Kaplan De-Nour, & Czaczkes, 1972). This is consistent with
evidence from research examining adherence to medications, where it has been estimated
that in 2/3 of the 750 million prescriptions written each year there will be partial or
complete nonadherence, and 33% of patients do not take medication in the prescribed
manner. In addition, 70% of all patients drop out of psychotherapy after the 3rd session,
and approximately 40% of hypertensive patients fail to practice relaxation exercises as
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prescribed (Meichenbaum & Turk, 1987). Furthermore, it has been found that long-term
dietary adherence (2-5 years) can be predicted from as early as the first 20 sessions of HD
(Agashua, Lyle, Livesley, Slade, Winney, & Irwin, 1981). However, not everyone is
convinced of the adherence – health outcome relationship. There is contradictory
evidence regarding the ability to differentiate adherers without medical complications and
nonadherers with medical complications on the basis of adherence measures (Manley &
Sweeney, 1986). At any rate, Turk and Meichenbaum (1991) warn researchers that strict
adherence to a medical regimen may not result in predictable long-term effects.
Probably the most difficult aspect of HD patients’ treatment regimen is fluid
restriction because of the stress caused by the extensive behavior change required
(Hoover, 1989; Rosenbaum & Ben-Ari, 1986). As a result of kidney failure many patients
produce no urine; therefore, any fluids consumed are retained within the body. Short-term
effects of fluid overload include nausea, dizziness, muscle cramping, shortness of breath,
and exacerbated hypertension; long-term effects are congestive heart failure, pulmonary
edema, accelerated disease processes, and death (Kaplan De-Nour, 1981; Tracey, Green,
& McCleary, 1987).
It is no surprise, then, that the most pervasive problem with the treatment regimen
is fluid nonadherence (Streltzer & Hassell, 1988). Past studies report fluid nonadherence
rates of 30% to 60%, depending on the criterion used (Christensen, Benotsch, & Smith,
1997). A large, multi-treatment center study reported that 49.5% of the patients were
nonadherent to fluid restrictions (Bame, Petersen, & Wray, 1993). Comparisons between
U.S. HD patients and those from Sweden and Japan show that Americans have
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significantly lower survival rates, and that treatment nonadherence, such as missing HD
sessions, is at least partially responsible for this difference (Bleyer, Hylander, Sudo,
Nomoto, de la Torre, Chen, & Burkart, 1999). The authors suggested that differences in
patient autonomy may be a reason for such gross nonadherence, with greater autonomy in
the U.S. to make decisions regarding one’s treatment, which may inadvertently prevent
physicians from directly influencing decision making.
The problem of nonadherence in the medical population is frequently addressed in
the research literature, yet findings are often convoluted, contradictory, and based on
patient self-report (Dunbar-Jacobs, J., 1993; Meichenbaum & Turk, 1987). From the
standpoint of frustrated physicians who treat HD patients: “When the care providers are
convinced that the reasons for noncompliance are not ignorance or misinformation, the
responsibility for adherence is on the patient” (Hoover, 1989, p. 957). From the patients’
point of view, treatment adherence is a kind of double-edged sword, in that it is quite
time-consuming and often only briefly delays death or serves as temporary symptom
relief. Therefore, to patients, the costs of adhering to treatment may outweigh the
perceived benefits (Turk & Meichenbaum, 1991). It has been suggested that patients
decide to change to more adherent health behaviors based upon their perception of how
the symptoms impact on their daily activities (Turk & Rudy, 1991). Interestingly,
hemodialysis patients who are not candidates for kidney transplants have demonstrated
greater adherence to treatment regimens (McGee, Rushe, Sheil, & Keogh, 1998).
It also has been suggested that HD patients are ideal for studying nonadherence,
as the treatment is long-term and because patients typically remain at the same center
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with the same physician, making contact readily available (Hoover, 1989). One difficulty
with research in this area is the dilemma of how to assess adherence. Meichenbaum and
Turk (1987) addressed the consequences of this problem and the need for establishing a
“gold standard” for adherence assessment:
The absence of reliable, valid, clinically sensitive indices of adherence is an
important problem because it can compromise clinical trials, lead to ordering of
unnecessary diagnostic tests or use of alternative medications, inhibit the
identification of reliable determinants, and consequently, hinder attempts to
establish appropriate treatment regimens. (p. 30)
In the domain of HD treatment, researchers examining fluid adherence have
employed interdialysis weight gain (IWG) as the measure of fluid intake between dialysis
sessions. In attempts to rely upon measures that are least affected by factors other than
the adherence behaviors of interest, biological markers (such as IWG) have been selected
because they are easily calculated and reliable (Manley & Sweeney, 1986). There is
evidence that the mean IWG increases during the summer months, as would be expected
(Manley & Sweeney, 1986). Even so, much evidence has been established demonstrating
that IWG is highly reliable, is indicative of drinking behaviors since the last HD session,
and is relatively unaffected by extraneous factors (Christensen, Smith, Turner, Holman,
Gregory, & Rich, 1992; Moran, Christensen & Lawton, 1997). It has also been found that
IWG is not influenced by HD treatment adequacy during sessions (Kobrin, Kimmel,
Simmens, & Reiss, 1991). IWG has repeatedly been shown to be unrelated to other
measures of HD adherence, namely serum potassium and serum phosphorus levels which
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are measures of diet and medication adherence, respectively. This further validates the
assertion that IWG is correlated with drinking behavior alone. Therefore, for HD patients,
the most important aspect of the treatment regimen is explicit and easily measured by
objective means – if the patient drinks fluid, weight is gained (Kaplan De-Nour &
Czackes, 1972).
A number of psychological variables have been examined for their possible
relationship with fluid nonadherence. These include demographics (Bame et al., 1993;
Hartman & Becker, 1978; Meichenbaum & Turk, 1987; Morduchowicz, Sulkes, Aizic,
Gabbay, Winkler, & Boner, 1993; Procci, 1978; Wolcott, Maida, Diamond, & Nissenson,
1986); social support (Christensen, Smith, Turner, Holman, Gregory, & Rich, 1992;
Cummings, Becker, Kirscht, & Levin, 1982; Hartman & Becker, 1978; Reiss, Gonzales,
& Kramer, 1986); internal locus of control (Blackburn, 1977; Bollin & Hart, 1982;
Oldenburg, MacDonald, & Perkins, 1988; Moran et al. 1997; Poll & Kaplan De-Nour,
1980; Schneider, Friend et al., 1991; Wiebe & Christensen 1996); health beliefs
(Cummings et al. 1982); personality (Wiebe & Christensen, 1997); self-efficacy (Brady,
Tucker, Alfino, Tarrant, & Finlayson, 1997; Friend, Hatchett, Schneider, & Wadhwa,
1997; Rosenbaum & Ben-Ari Smira;1986); stress (Christensen, Benotsch, Wiebe, &
Lawton, 1995; Everett, Brantley, Sletten, Jones, & McKnight, 1995); depression (Everett
et al., 1995; Friend et al., 1997;) and body consciousness (Christensen, Wiebe, Edwards,
Michels, & Lawton,1996). However, after more than 25 years of research in this area it is
evident that no consensus exists. Several literature reviews have examined the
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relationship between various psychological factors and/or models and fluid adherence in
HD patients (Hoover, 1989; Levenson & Glocheski, 1992; Sensky, 1993; Stewart, 1983).
Although much research has been conducted on psychological predictors of fluid
nonadherence, there is little research on interventions to treat the problem. This is
surprising considering the significance of restricted fluid intake to the survival of
hemodialysis patients, as well as the magnitude of nonadherence to this restriction.
Interventions to address the problem of fluid nonadherence have generally been
behavioral. Since the first study in this area in 1976, there have been only 11 systematic
investigations addressing interventions for fluid nonadherence in adult HD patients.
These include a study that focused on fluid nonadherence in children, as well as three
unpublished dissertations. There is clearly a need for further research in this area of
health psychology. The following is a critical review of the research thus far.
Barnes (1976) was the first investigator to examine the effect of an intervention
on fluid nonadherence in an adult HD patient. A token economy was implemented for an
inpatient with severe chronic fluid overloading. The patient was able to earn points for
consuming less than a prescribed limit, and extra points could be earned for less than a 1
kilogram (kg) (2.2 lb.) daily weight gain. He was allowed to exchange the points for
special food and was also verbally praised by staff members for regimen adherence.
Weight gain decreased to an average of 1.3 kg per day, and the patient voluntarily
remained on the token economy for 6 weeks. However, no data regarding baseline IWG
or specific weight gains were provided.
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Hart (1979) also used token economy to treat 10 chronic fluid overloaders, and his
study is the only empirical investigation to date that considered patients’ dry weights
when measuring fluid nonadherence. Coupons, exchanged for special food, were
contingent upon meeting one of two weight gain goals: 5 coupons were given for IWG
within 2% of one’s dry weight, while 2 coupons were given for IWG within 5% of one’s
dry weight. Employing percent change statistics and mean group weight, Hart showed
that the weight gains went from 167 - 168 lb. (76 kg) at baseline, to 161 - 163 lb (73 kg)
post-treatment - a 3% to 3.6% reduction from baseline. No follow-up data were provided.
Magrab and Papadopoulou (1977) found that when the IWG of children, ages 11
to 18 years, were posted on charts and points were given for prizes or money, a 45%
reduction in average weight gain was observed. IWG baseline average was 1 kg, and
during treatment the average dropped to 0.44 kg. It is noteworthy that the investigators
determined prior to the study an IWG limit of 2 lb., or 0.9 kg, which was essentially the
same as the baseline average. Therefore, these participants were minimally nonadherent.
There was no follow-up.
Skoutakis, Acchiardo, Martinez, Lorisch, and Wood (1978) examined the effects
of pharmacist involvement on regimen adherence, including IWG. Following baseline
measures, 24 HD patients met with a pharmacist two to three times per week for 4
months for information that included educational materials, consultation regarding their
health, disease state, life expectancy, and written reminders for taking medications.
Patients demonstrated improvements in areas that included adherence and for half of the
patients randomly chosen to continue the intervention for an additional 4 months,
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adherence measures continued to improve. For those who did not continue the program
and received only standard HD treatment, adherence returned to baseline levels. It is
important to note, however, that the adherence “measures” were actually rankings of all
the biochemical data into categories ranging from “excellent” to “poor.”  Excellent
adherence was considered to be weight gains equal to or less than 0.5 kg between dialysis
sessions and poor adherence described weight gains of 2.0 kg or more between sessions.
This ranking system is clearly too stringent and generally inconsistent with recent studies,
where typically it is considered that between-session weight gains ranging from 2.0 kg to
3.0 kg are indicative of desirable adherence.
Behavioral contracts have been somewhat effective in improving adherence to
fluid regimens. Cummings, Becker, Kirscht, and Levin (1981) utilized a pretest-posttest
control group design to demonstrate that patients who signed a 6-week behavioral
contract, that included a family member or friend’s involvement in activities, had lower
mean IWG than when the contract excluded outside support. Comparison of the former
intervention’s effects with baseline IWG shows a 16% reduction in mean IWG, with
results generally maintained at 3-month follow-up. Weekly phone calls that attempted to
alter patients’ health beliefs had little effect. It should be noted that the behavioral
contracting intervention was actually in addition to positive consequences (state lottery
tickets contingent on meeting previously agreed upon goals). Therefore, it is unclear as to
which component(s) actually contributed to the observed effect. Furthermore, baseline
average weight gains were based upon data from only six dialysis sessions, hardly
enough to establish a stable sampling of nonadherent behavior.
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Keane, Prue, and Collins (1981) employed a combination of behavioral
techniques, including behavioral contracting, to demonstrate effectiveness in decreasing
IWG. For the first case study, the authors implemented a contract that scheduled morning
sessions (preferred by the patient) contingent upon meeting criterion 10 out of 12
consecutive sessions. This patient’s baseline mean IWG was 2.15 kg over 9 weeks, and
the criteria were IWG of 1.5 kg for Wednesdays and Fridays, and 2.5 kg for Mondays.
The patient was an overweight (76 kg) female. Over the course of 25 sessions, staff
praised the patient and engaged in increased social interactions when she met criteria, and
she was taught to graph her IWG. Following implementation of the contract, her mean
IWG was 1.42 kg, or a 34% reduction from baseline. IWG increased with design reversal,
and again decreased to 1.45 kg when the contract was reinstated.
The second patient in the study was a male who weighed less than patient 1 (63
kg, as compared to 76 kg), but his baseline mean IWG was more severe (3.6 kg). The
authors set his criteria at 3 kg on Wednesdays and Fridays, and 3.5 kg on Mondays. The
implementation of a special meal contingency, staff praise and socialization with goal
attainment resulted in a mean IWG of 2.7 kg, and 2.4 kg when the intervention was
reinstated after reversal, or 25-33% reductions in IWG from baseline. It is unclear as to
which component actually contributed to the decrease in IWG - behavioral contracting or
social reinforcement or both.
Finn (1985), in an unpublished dissertation, employed a multiple baseline across
participants design to examine the effects of feedback, praise, and a contracted
reinforcement with 6 participants. Compared to feedback alone or in combination with
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praise, only 1 of the 4 participants who completed the study attained the criterion of IWG
in the condition that combined all three interventions. It may be concluded that the
contracted reinforcer was the variable that contributed most to the observed effects. There
were no follow-up data.
Two other dissertations in the 1980’s attempted to demonstrate the effectiveness
of various interventions on IWG in HD patients. While details of the studies were
unavailable, abstracts indicated that alternative treatments for nonadherence, such as
guided imagery, were equivocally effective. While Morrissey (1985) used a pre-post
experimental/control group design and found no effect of audiotapes on ability to
maintain “compliance,” Higgins (1985) found that a higher ability level with guided
imagery was associated with a decrease in weight. Details about the research design were
unavailable.
Hegel, Ayllon, Thiel, and Oulton (1992) conducted a sophisticated study to
compare behavioral and cognitive approaches. Study 1 compared a traditional Health
Belief Model intervention (THBM) to a behavioral intervention combined with an
abbreviated version of the Health Belief Model (CHBM) that was contingent upon failure
to meet contracted criteria. The THGM intervention included gathering information
regarding barriers to adherence, problem solving to overcome these barriers, provision of
information about negative health consequences and the benefits of good adherence, and
the correction of misconceptions. This was contrasted with a behavioral intervention
comprised of incentives for 24-hour weight gains of less than 2 lb., or approximately 1kg.
These incentives were ranked according to preference with the top three incentives
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differentially provided according to three levels of criterion stringency, the most
preferred incentive being given for attainment of the most stringent goal. As part of the
behavioral intervention, a brief session of an abbreviated Health Belief Model (CHBM)
was implemented contingent upon failure to meet the contracted minimum 24-hour IWG,
and its purpose was to clarify misconceptions and provide further information.
The mean 24-hour IWG for the 4 patients during standard dialysis treatment was
1.68 kg (or approximately 3.36 kg between sessions). Although, implementation of
THBM resulted in a large decrease in 24-hour IWG, results were short lived and weight
gain quickly increased within one to six sessions. However, the combined reinforcement
and CHBM intervention resulted in 24-hour mean IWG of 0.75 kg (1.5 kg between
sessions). In order to examine maintenance of effects, at the end of this study patients
were taught to monitor their own 24-hour IWG and to graph their results. During this
maintenance period if a patient did not meet criterion, he was given a cueing checklist
requiring him to indicate if several recommendations for limiting fluid intake were
followed. Results were maintained at 2-month follow-up.
The authors then compared, in a second study, the reinforcement and CHBM
components of their study 1 to examine if one or both were responsible for the observed
effects. Three patients were either reinforced for meeting 24 IWG criteria or they
received the contingent Health Belief Model for failure to meet criteria. In an A-B-AC-
BC multiple baseline design across participants, the authors found that reinforcement
alone produced a 44% decline from standard treatment, from a mean of 2.48 kg to 1.39
kg. A return to standard dialysis treatment, but with CHBM added, resulted in a
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deterioration trend; however, the rate of relapse was slower than with the THBM of the
previous study. When reinforcement and CHBM were combined in a final phase, results
showed consistent improvement, with an average 24-hour IWG of 0.99 kg. Results were
maintained below criterion at 2-month follow-up.
Hegel et al. (1992) suggested that the results of their second study might have
been due to sequence effects, namely that presenting reinforcement first resulted in its
being more effective. In a third study, an AC-B-BC design showed that the CHBM
intervention resulted in immediate 24-hour IWG decreases, with a quick deteriorating
trend but a slower relapse rate. Introduction of reinforcement alone was followed by a
marked drop and an improving trend. Again, when the combined intervention was
introduced, the improvement trend continued. The authors suggested that the
reinforcement component alone was the most effective component of the treatment
program, and administration sequence had no effect on results. They also concluded that
the CHBM’s value may be in retarding the rate of relapse. As was posed by the authors,
there remains the issue of which component of the behavioral intervention was
responsible for the effects – the behavioral contract or incentive. Furthermore, as was
suggested by the authors, the 2-month follow-up was probably too brief.
Mosley et al. (1993) employed contingent social reinforcement to treat fluid
nonadherence in an obese female of borderline intelligence. Her 4-week baseline mean
IWG was 4 kg and the IWG criterion was set at 3 kg, based upon the mean IWG for the
dialysis facility where she was treated. During the first intervention the patient was
shown a 20-min videotape three times for 1 week. It was also shown to all patients at the
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center to control for potential attention effects. Following the education intervention,
social reinforcement contingent upon criterion attainment was provided for 4 weeks in
the form of public posting of data graphs and staff praise. During the 4-week baseline
period, the patient met the IWG criterion only 8% of the time as compared to 33% of the
time following the education program, and 67% of the time during the social
reinforcement phase. It was noted that she met the criterion 100% of the time during the
last week of the program (social reinforcement). Results were maintained at 3- and 6-
month follow-up.
Mosley et al. (1993) concluded that social reinforcement alone was most effective
for decreasing IWG with this patient, without combining this intervention with behavioral
contracting or token economies. However, as was suggested by Hegel et al. (1992) in
their study, it is possible that the efficacy of contingent social reinforcement was
influenced by the education phase presented before it. In other words, there was a
possible sequence effect that was unaddressed. Although Hegel et al. (1992) found that
the order of treatment presentation, namely reinforcement first, did not influence the
Health Belief Model’s effectiveness, it is possible that education presented prior to social
reinforcement could enhance the latter’s effectiveness. There is some evidence that
education is associated with increased treatment adherence (Skoutakis et al., 1978).
While most of these interventions yielded positive results, there are criticisms of
the research. Methodological problems include inadequate or no baseline data (Barnes,
1976; Cummings et al., 1981). Some investigators examined HD patients whose baseline
data were within normal limits or employed IWG cut-offs that were the same as baseline
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data (Magrab & Papadopoulou, 1977). Other researchers categorized participants into
broad categories based on composite measures of adherence and assigned labels ranging
from “poor” adherence to “excellent” adherence. There is evidence that individual
measures of adherence are unrelated, which casts doubt on the validity of composite
measures of adherence (Sensky, Leger, & Gilmour, 1996).
Another criticism of the research is that conclusions are rather tenuous because of
the arbitrary IWG cut-offs used to indicate adherence. IWG criteria varied by study and
ranged from 0.5 kg to 3 kg. At least one study did not specify IWG cut-offs (Cummings
et al., 1981). Hart (1979) was the only investigator to consider individual body size and
weight gain tolerance. Furthermore, while absolute IWG has been found to be a reliable
measure of drinking behavior (Manley & Sweeney, 1986), it may not be appropriate to
use the same criterion for all participants within a study. This is because a 2-kg
(approximately 4.5 lb.) weight gain for an 80-kg individual is not as significant as that for
a 60-kg individual. In other words, larger patients may tolerate larger weight gain and do
so without negative consequence. Therefore, Sensky (1993) suggested that rather than
using arbitrary cut-off points between “low” and “high” weight gains, a fraction of ideal
weight should be used. 
Manley and Sweeney (1986) have also argued that cut-offs have been set
impressionistically and, as a result, estimates of nonadherence have likely been
artificially inflated. Few published studies have attempted to correct IWG criteria for this
effect, as suggested by Manley and Sweeney (1986) and Wolcott et al. (1986).
Furthermore, these cut-offs were constructed on the basis of presumed appropriate levels,
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without reference to data on the actual range and distribution, which likely results in
inflated rates of nonadherence (Manley & Sweeney 1986). This might occur because
there is no IWG standard set by a well-recognized authority, such as the Health Care
Financing Administration (HCFA; Bame et al., 1993). Also, the opinions of physicians
and nurses regarding the ideal IWG have differed even within the same treatment center
(Agashua, Lyle, Livesley, Slade, Winney, & Irwine, 1981). Although various weight gain
limits have been used as criteria in many studies, there is a paucity of empirical evidence
demonstrating that these particular values (0.5 kg – 3 kg) result in demonstrable health
complications (Manley & Sweeney, 1986).
A limitation of stringent IWG cut-offs is that a patient's body size biases the
amount of fluid intake tolerated (Bame et al., 1993). Therefore, in addition to the stress of
attending 4-hour HD sessions three times per week and restricting one's diet, medical
staff may be imposing additional and unnecessary stress on patients by holding them to
these unrealistic IWG limits (Manley & Sweeney, 1986).
A potential solution to this problem is to use an adherence measure that takes into
account the individual patient's weight and what he or she can physically tolerate. Dry
weight is a figure based on the body weight at which a patient begins to develop
symptomatic hypotension after fluid removal or weight without any “extra” fluid on the
body (Manley & Sweeney, 1986). It has been suggested that a ratio of the IWG and the
patient's optimal dry weight be used instead of absolute IWG as to account for a patient’s
body size (Bame et al., 1993), although support for this measure is not unanimous
(Manley & Sweeney, 1986). However, dry weight ratios have been found to be highly
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correlated with absolute IWG, r=.80 (n=34) and, when the ratio was compared to staff
ratings of patient adherence, correlations remained high, r=0.66 (n=34).
Researchers have suggested IWG of less than 3% of a patient's dry weight as a
measure that would simplify, as well as standardize, the approach to fluid adherence
assessment (Wolcott et al., 1986). This criterion relates IWG to individual dry body
weight so that it controls for variations in body size, and is also moderate in its goal. Such
a realistic goal keeps the HD patient within the boundaries of physical tolerance and
health, and it is also achievable. In 1986, Wolcott et al. argued that future research should
address the need for the most reliable and valid methods of adherence measurements and
effective interventions based on individual factors. Research should focus upon
developing individually tailored treatments that employ IWG criteria controlling for body
size, and that are more likely to result in long-term effectiveness. Another advantage is
improved accuracy of prevalence statistics and standardization of fluid adherence
measures.
Mosley et al. (1993) observe that while evidence supports behavioral
interventions for reducing IWG, these interventions typically have been treatment
packages involving several components (i.e., behavioral contracting, social
reinforcement, rewards, etc.)  Although there have been recent attempts to disentangle
treatment components most responsible for behavior change (Hegel et al., 1992; Mosley
et al., 1993), Finn and Alcorn (1986) suggest that much more research still is needed to
examine the efficacy of individual treatment components. Furthermore, addressing the
relative merits of components requires consideration of possible sequencing effects when
21
adding interventions. Hegel et al. (1992) were the first and, to date, the last investigators
to examine that particular confound in this area of adherence research.
Present Study
This research has been reviewed and approved by the University of North Texas
Committee for the Protection of Human Subjects. Before formal research began, and in
order to examine relevant clinical issues, baseline data and 17 weeks of pilot data were
gathered on a 57-year-old male who has been on dialysis for 2 ½ years. Sequential
interventions implemented were: a) self-monitoring of fluid intake and diet; b) monetary
rewards for taking data on a daily basis; c) monetary rewards for decreasing high sodium
foods, and d) monetary rewards for meeting Monday weight gain goals. Based upon the
data, these interventions collectively had an effect on the patient’s adherence behavior
and IWG in terms of the fluid intake amounts and decreased dietary sodium intake.
The present study investigated the sequential and additive effects of two
components of a behavioral treatment package, specifically self-monitoring and monetary
reward, with the goal of reducing IWG. In addition to examining the relative merit of
treatment components in decreasing IWG, the present study implemented a new,
standardized IWG criterion that is individualized for dry weight. The new standard, as
suggested by Wolcott et al. (1986), used 3% of a patient’s dry weight as the cut-off
criterion for fluid adherence. However, the authors provided no details as to acceptable
allowances over longer interdialysis periods (e.g., weekends). Therefore, the criterion
during weekly sessions, or when there were only 2 days between HD sessions, was 3% of
dry weight and the weekend weight gain criterion, or when there were 3 days between
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HD sessions, was 4% of dry weight. Cut-offs based upon percentage of dry weight are
more lenient for individuals with larger body weights but are slightly more stringent for




Approximately 45 potential participants at two Dallas-area HD outpatient centers,
whose HD schedules coincided with that of the investigator’s, were approached to
volunteer for the study. Permission to view medical charts was sought from those who
had been on HD for at least 6 months and to identify participants whose adherence had
not improved during at least the previous 6 months. Sixteen volunteers met this criterion,
and of this subgroup nine volunteers were identified as chronic fluid overloaders,
operationally defined as having weight gains greater than 3% of their dry weight for
weekday HD sessions and greater than 4% of their dry weight over the weekends. Three
participants dropped out of the study, leaving a total of 6 participants, 4 men and 2
women. All were either on a kidney transplant list or were in the process of applying for a
transplant. Their average age was 43 years and their average length of time on dialysis
was 41 months. The study included 4 Caucasians, 1 Hispanic, and 1 African-American.
Dependent Measure
Interdialytic weight gain (IWG), determined by subtracting the post-dialysis
weight (kg) for the previous session from the pre-dialysis weight for the current session,
was the dependent measure. IWG is considered a fairly direct indication of fluid
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consumption since the last HD session and has been demonstrated to be a reliable
measure of fluid adherence. IWG is relatively unaffected by extraneous factors such as
acute medical illness (Christensen, Smith et al., 1992). Studies have shown correlations
among IWG measures from 2 to 12 months to range from .57 to .78, which demonstrates
the stability of IWG as a dependent variable (Lamping, Campbell, & Churchill, 1988;
Rosenbaum & Ben-Ari Smira, 1986; Schneider, Friend, Whitaker, & Wadhwa, 1991).
Independent Variables
Self-monitoring. Self-monitoring alone has been shown to result in behavior
change (Nelson, 1977). However, when used for the treatment of nonadherence, self-
monitoring has received equivocal support with diseases such as hypertension, diabetes,
obesity, smoking, anorexia, and epilepsy (Cinciripini, Kornblith, Turner, & Hersen, 1983;
Epstein, 1981; Gibbered, Dunne, Handley, & Hazelman, 1970; Mullen, Simons-Morton,
Ramirez, Frankowski, Green, & Mains, 1997; Nessman, Carnahan, & Nugent, 1980).
Recent evidence has supported its use for maintaining long-term treatment effects (Hegel
et al., 1992). In the present study, the self-monitoring component consisted of
participants’ collecting data daily on fluids consumed and diet intake. Personal preference
determined whether data were recorded by making slashes onto pre-printed sheets
supplied by the investigator, or handwritten entries (see Appendix).
Monetary rewards. Monetary rewards were scheduled for delivery in a titrated
manner according to three graduated levels of IWG criteria. The most money ($3) was
earned for meeting the 3% and 4% of dry weight criteria for sessions with 2 days and 3
days in between, respectively. Less money ($1.50) was earned for weight gains of 3.3%
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and 4.3% of dry weight, and the least amount of money (50 cents) was earned for weight
gains of 3.5% and 4.5% of dry weight. The three reward levels were used in an attempt to
ensure that any improvement would be rewarded to some extent. All participants were
given a schedule that described their specific cut-offs and rewards. Monetary rewards
were distributed for each dialysis session (three per week); therefore, it was possible for a
participant to receive a total of $9 per week if the most stringent criteria were consistently
met.
Experimental Design
The design was a single subject experimental design (Hersen & Barlow, 1976).
To test the efficacy of the independent variables individually and in combination, the
participants were presented with an A-B-BC-B-BC design. However, because it is
possible that the order in which the two independent variables were presented
individually would affect the results (i.e. sequence effect), an A-C-BC-C-BC was used
for half of the participants. Thus, half of the participants were asked to begin the study
with self-monitoring first and the other half began the study with the monetary reward.
Procedures
Following a 6 - 9-week baseline period (depending upon the stability of the
participants’ baselines) during which IWG data from participants’ medical charts were
gathered, the clinician/investigator began meeting with each participant twice per week
for approximately 50 min per session. During the first three behavior therapy sessions,
the focus was on establishing rapport, gathering personal and medical histories, as well as
acquiring baseline information on each patient’s fluid intake, diet, and salt intake. In the
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third therapy session, all patients were asked to monitor their fluid and diet intake for 1
week to identify potentially problematic situations and specific drinks/foods on which to
focus treatment. During this week, IWG data were collected but there were no meetings
with the clinician/investigator. All participants then were shown a graph of their baseline
data during the fourth therapy session, 1 week later. This session began the first 4-week
treatment phase, consisting of two therapy sessions per week, in which half of the
participants continued monitoring and the other half received a monetary reward for
meeting criteria. It was also during the fourth therapy session that each participant was
informed of the specific IWG treatment goals (based upon 3% and 4% of their dry weight
for weekdays and weekends). They were given a page describing the effects of chronic
fluid overload. During each therapy session throughout the study, for all 6 participants,
strategies for controlling fluid intake were discussed and given as “homework”
assignments. Examples of strategies included: gradually decreasing the frequency of
drinks consumed on a daily basis; decreasing consumption of high-sodium foods;
drinking from smaller cups; chewing gum or eating hard candy when thirsty; sucking on
a lemon slice; not refilling drinking glasses; and taking medications with meals. Problem-
solving strategies were discussed, situations in which participants were more likely to
drink were identified, and attempts were made to rearrange the environmental
contingencies. For all participants, verbal praise was given for accomplishing homework
assignments, meeting goals, progress, etc., and they were shown graphs of their progress
at the beginning of each phase. During monitoring phases, data regarding fluid and diet
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intake were discussed; any foods that contributed to an increase in IWG (high sodium,
soup, etc.) were a focus of change.
During the second 4-week phase of the study, a second intervention was added to
the first; i.e., participants both monitored their daily intake and received a monetary
reward for meeting criteria. During the third 4-week phase the second interventions were
discontinued; that is, participants were asked to either discontinue the monitoring that had
been added or they were informed that the monetary reward added in the previous phase
would no longer be provided. In the final 4-week phase, both interventions again were
implemented together. At the final meeting, participants were shown graphs of their
individual data and debriefed as to the details of the study.
Results
Treatment results are presented in three ways. First, overall results are
summarized. Then commonalities across participants are reported, first for weekend data
and then for weekday data. Finally, the effects of treatments on IWG of individual
participants are analyzed for weekends and weekdays.
Baseline IWG
All IWG baseline data were gathered from the patients’ medical records. Due to
differences in the number of days between weekday and weekend HD sessions, the IWG
data were separated into weekend data and weekday data, and the dry weight criteria
were applied (3% between weekday sessions and 4% over the weekend). The average
baseline IWG over the weekends was 5.5 kg, and the average baseline IWG between
weekday sessions was 3.9 kg. Severity of nonadherence was most readily apparent in the
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data for the male participants (who typically weigh more), whose average baseline IWG
over the weekends was 6.6 kg, and average baseline IWG during the week was 4.45 kg.
Overall Treatment Results
By the end of the treatment program, all 6 participants showed a reduction in
average weekday IWG from baseline to final treatment phase (see Table 1). The IWG
reductions averaged .53 kg (1.17 lb.) and individuals ranged from an average reduction of
.1 kg (.22 lbs.) to 1.1 kg (2.42 lbs.). Four out of the 6 participants also reduced their
average IWG for weekends. The average weekend IWG reduction for these 4 participants
was .85 kg (1.87 lb.) and ranged from .5 kg (1.1 lb.) to 1.4 kg (3.1 lb.). Of the remaining
2 participants, 1 remained approximately the same from baseline to the final treatment
phase for both weekend and weekday, and the other participant’s results were mixed,
with a gradual increase in weekend IWG (3.4 kg or 7.5 lb.). The overall reduction in IWG
from baseline to final treatment phase for these 4 participants averaged .75 kg (1.65 lb.).
However, despite these observed differences, significant variability in the data make it
impossible to establish relationships between variables and true effects of the treatment
variables.
Two variables, monitoring and monetary reward, were manipulated and compared
for treatment effects, both individually and in combination. Each half of the participants
were presented with one of the two variables first. Data for two of the participants
showed effects of a manipulated variable for weekends, weekdays, or both. Participant
1’s average weekend IWG reduction of .5 kg (1.1 lb.) (see Table 1), which was 7.6%
lower than baseline, and average weekday IWG reduction of .8 kg (1.76 lb.), 17.4%
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lower than baseline, were clearly related to the monitoring of daily fluid and diet intake.
Participant 5’s average weekend IWG reduction of .7 kg (1.54 lb.) (see Table 1), which
was 21.2% lower than baseline, was related clearly to the combined treatment package of
monetary reward and monitoring. However, although this participant’s weekday IWG
was reduced by 1.1 kg (2.42 lb.), which was 35.5% lower than baseline by the end of
treatment, this reduction was not consistently related to a particular treatment variable.
Although participants 3, 4, and 6 ended the treatment program with IWG averages
lower than baseline levels, these results did not relate to any specific treatment variable
(see Table 2). Participant 2’s average weekday IWG reduction of .5 kg (1.1 lb.) by the
end of the program, which was 12% lower than baseline, also was not accounted for by
any particular treatment variable, and neither was the observed increase in weekend IWG
(see Table 1). A similar observed increase in participant 6’s average, weekend IWG was
also not related to any of the treatment variables (see Table 1). The 1-week, rapport-
building phase was not consistently related to reductions in weekend IWG, and the
average IWG of several participants increased during this period. However, weekday
IWG reductions ranged from .2 kg - .8 kg for 4 out of 6 participants, so nonspecific
treatment variables, such as attention, may have accounted for obtained reductions in
weekday IWG for some participants and obtained increases in others.
Comparisons Across Participants
Weekends. During the initial rapport-establishing and history-gathering
introductory sessions, 5 out of 6 participants showed increases in their weekend IWG
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averages over their baseline averages. These 5 participants averaged an IWG increase of
approximately 20% (.92 kg or 2 lb.) (Table 3, column 1).
During the first treatment phase where each participant received one or the other
treatment components, 4 out of 6 participants (1, 3, 5, and 6) had moderate to very large
reductions (12.8% - 35.1%) in weekend IWG. Their average weekend IWG reduction
was 1.3 kg (2.9 lb.) regardless of which treatment was in effect. Specifically, for those
who monitored their fluid and diet intake, 2 out of 3 participants (1 and 3) showed
moderate to very large weekend IWG decreases (13% - 35.1%). Similar effects occurred
for those who received monetary rewards, with 2 out of 3 participants (5 and 6)
demonstrating moderate to very large (12.8% - 25.5%) weekend IWG reductions.
The addition of a second variable (monitoring or reward) during the combination
phase resulted in moderate to very large (9.5% - 26.5%) IWG reductions for 3 out of 6
participants (2, 4, and 5; see Table 3), or an average IWG reduction of .8 kg (1.76 lb.).
This combination had no effect on a fourth participant (6), who maintained the very large
decrease (25.5%) from the prior reward-only phase. Of the 3 participants who showed
further IWG reductions in the combination phase, 2 were in the reward-first condition
(participants 4 and 5).
The return to previous conditions (monitoring-only or reward-only) resulted in
small to moderate (3% - 14.3%) IWG reductions for participants 1, 4, and 6, or an
average IWG reduction of .5 kg (1.1 lb.). Two of the 3 participants (4 and 6) were in the
reward-first condition (Table 3). The final combination phase of the study was associated
with similar results as the previous combination phase, with 3 of the 6 participants (3, 4,
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and 5) demonstrating small to very large (4.6% - 25%) reductions in IWG, or an average
IWG reduction of .9 kg (1.98 lb.)  Two of the 3 participants (4 and 5) were, again, the
same participants in the reward-first condition who showed decreases in the first
combination phase. However, the third participant (3) to show a decrease in the final
combination phase was not the same as the one who showed a decrease in the first
combination phase (participant 2).
In summary, weekend IWG generally increased considerably over baseline levels
during the initial information-gathering period. Introduction of either treatment variable
was associated with decreases in weekend IWG for most of the participants. Adding the
second variable was associated with some IWG reductions but had no systematic effect
across participants, in that the effect was observed for only 2 participants. No further
systematic effects of the two treatment variables were observed in weekend data across
participants.
Weekdays. Contrary to the weekend IWG data, the initial rapport-establishing and
history-gathering introductory sessions were associated with small reductions in weekday
IWG (6.5% - 9.8%) in 3 out of the 6 participants (1, 3, and 6), or an average of .3 kg (.66
lb.) (see Table 3, column 2). A fourth patient (5) showed a large reduction in IWG
(25.8%) or .8 kg (1.76 lb.) during this phase. During the first treatment phase, where each
participant received either of the two components, 2 of the 6 participants (1 and 4)
showed reductions in IWG, and both were moderate effects (10.2% and 16.3%). Their
average IWG reduction was .45 kg (.99 lb.) regardless of order of treatment presentation.
This effect was much smaller than that observed for the weekend data, where 4
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participants showed moderate to very large IWG reductions after the first phase,
regardless of condition. It should be noted that of the 2 participants who did show
reductions in weekday IWG, 1 participant (4) never received the monetary reward during
the study, as the goals were never attained. Thus, the monetary reward could not be said
to have had an effect. The remaining 4 participants (2, 3, 5, and 6) showed increases in
IWG that averaged 9.3% over the previous phase, or .25 kg (.55 lb.).
The addition of a second variable (either monitoring or the monetary reward)
during the combination phase was accompanied by small to very large reductions in IWG
(2.3% - 30%) for 4 out of the 6 patients (2, 3, 5, and 6), 2 participants from each
condition (see Table 3). The average IWG reduction for these participants was .38 kg (.84
lb.). Of the 2 participants who showed increases in IWG during this phase, one showed
an increase that was 36.1% and the other showed an increase that was 4.6% over the
previous phase.
A return to isolated conditions (monitoring-only or reward-only) was
accompanied by generally moderate IWG reductions (9.5% - 16.3%) for participants 1, 5,
and 6 (see Table 3) or an average IWG of .43 kg (.95 lb.). Two out of the 3 participants
belonged to the monetary reward-first condition (5 and 6). The remaining 3 participants
(2, 3, and 4) showed average IWG increases of 23.4% over the previous phase, ranging
from .4 kg to 1.3 kg. These results were similar to the weekend data.
The final combination phase, in which the second variable was once again added
(monitoring or reward), was associated with small to very large IWG reductions (7.3% -
33.9%) for 4 out of the 6 participants (1, 2, 3, and 4), replicating overall results from the
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previous combination phase (see Table 3). The average IWG reduction was .88 kg (1.9
lb.). The addition of monitoring had no effect on a fifth participant (5), who maintained a
moderate decrease in IWG from the previous phase, and participant 6 gained an average
of .6 kg (1.32 lb.) over the previous phase’s average. Of the 4 participants who showed
IWG decreases, 3 were in the monitoring-first condition (1, 2, and 3). It should be noted,
however, that although the overall results were similar, the participants who
demonstrated IWG reductions in the final combination phase were not always the same
participants who had reductions in the first combination phase (see Table 3).
In summary, weekday IWG generally decreased slightly from baseline levels
during the initial information-gathering period. Introduction of either treatment variable
generally had no effect on decreasing weekday IWG for most participants. Adding the
second variable was associated with some IWG reductions but, similar to weekend
results, there were no systematic effects across participants in that the effect was
observed for only 3 participants. No further systematic effects were observed with the
return to individual treatment variables alone, but the final combination phase resulted in
IWG reductions for most participants. Due to enormous variability in the data, it is
impossible to conclude that there was a direct relationship between the independent
variables and observed effects.
Individual Analysis
Participant 1 – monitoring first. By the end of the treatment program, participant
1’s average weekend IWG was .5 kg (1.1 lb.) less than baseline average and his average
weekday IWG was .8 kg (1.76 lb.) less than baseline weekday IWG levels (see Table 1).
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Regarding weekend IWG, this individual demonstrated a small increase (4.5% or .3 kg)
during the brief information-gathering phase (Figure 1, upper graph). The introduction of
the monitoring intervention was associated with a moderate drop (13%) in IWG, from an
average IWG of 6.9 kg to 6.0 kg. The addition of the monetary reward contingency was
associated with a moderately large (16.7%) IWG increase of 1.0 kg (2.2 lb.), and the
removal of the reward contingency (return to monitoring alone) was associated with a
subsequent moderate (14.3%) reduction in IWG of 1.0 kg (see Figure 1). The final
combination phase resulted in a slight increase (1.7%) in IWG of .1 kg (.22 lb.). The .5
kg (1.1 lb.) reduction in the average weekend IWG at the end of treatment was associated
with to the monitoring intervention.
Regarding weekday IWG, participant 1 demonstrated a small reduction in
weekday IWG (6.5%) of .3 kg (.66 lb.) during the introductory phase (see Figure 1, lower
graph). When monitoring was in effect, participant 1 showed a greater reduction in IWG
(16.3%) or .7 kg (1.54 lb.). The addition of the monetary reward was accompanied by a
very large increase in IWG (36.1%) of 1.3 kg (2.86 lb.) to a level slightly higher than
baseline. Returning to monitoring alone was associated with a moderate IWG reduction
(16.3%) of .8 kg (1.76 lb.). However, the introduction of the monetary reward in the final
combination phase was associated with a further slight decrease in IWG (7.3%) of .3 kg
(.66 lb.). At conclusion of the study, the participant’s weekday IWG was 17.4% lower
than baseline and, as with weekends, monitoring is the variable that appears to account
for the reduction in average IWG.
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Participant 2 – monitoring first. By the end of the treatment program, participant 2
demonstrated a 54.8% increase in weekend IWG over baseline, or an average gain of 3.4
kg (7.48 lb.), but his average weekday IWG was .5 kg (1.1 lb.) less than baseline, an
11.9% decrease (see Figure 2). For weekend IWG, this participant demonstrated a large
increase (24.2%) of 1.5 kg (3.3 lb.) during the brief introductory phase, followed by a
further, small increase (5.2%) of .4 kg (.88 lb.) with the introduction of monitoring
(Figure 2, upper graph). A moderate reduction (9.9%) of .8 kg (1.76 lbs.) in IWG was
associated with the addition of the monetary reward contingency, followed by a very
large increase (22.9%) of 1.6 kg (3.52 lb.) when the reward contingency was removed.
The final combination phase was associated with a small IWG increase (7.9%) of .7 kg
(1.54 lb.), although it was a smaller or slower increase than that which occurred during
the previous monitoring-only phase.
Regarding weekday IWG results, a small increase (2.4%) of .1 kg (.22 lb.) was
observed during the introductory phase, followed by a continued small increase (2.3%) of
.1 kg with the introduction of monitoring (Figure 2, lower graph). The addition of the
monetary reward contingency was accompanied by a small reduction in weekday IWG
(2.3% or .1 kg). Removal of the reward contingency was associated with a very large
IWG increase (30.2%) of 1.3 kg (2.86 lb.). However, the final combination phase resulted
in a very large reduction (33.9%) in weekday IWG of 1.9 kg (4.18 lb.). It is uncertain as
to why this participant’s IWG worsened over the weekends but improved somewhat for
the weekday HD sessions. There is some evidence that the weekday IWG reductions
were attributable to the monetary reward in combination with monitoring, and its effect
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appeared to increase as the study progressed. For this individual, there was no evidence
that either treatment variable had a systematic impact on weekend IWG.
Participant 3 – monitoring first. By the end of treatment, participant 3’s average
weekend IWG was 1.4 kg (3.08 lb.) less than baseline, and his weekday IWG was .3 kg
(.66 lb.) less than baseline (see Figure 3). A moderate IWG increase (13.9%) of .9 kg
(1.98 lb.) was observed on weekends during the brief introductory phase (Figure 3, upper
graph). This individual showed a very large IWG reduction (35.1%) of 2.6 kg (5.72 lb.)
following the introduction of monitoring. The addition of the monetary reward was
associated with a moderate increase (14.6% or .7 kg) in IWG, followed by an even larger
increase (23.6%) of 1.1 kg (2.42 lb.) when the reward contingency was removed. The
final combination phase was associated with a large IWG reduction (25%) of 1.7 kg (3.74
lb.). However, since replication of the initial weekend IWG reduction during the
monitoring phase was unsuccessful, it is not certain whether any specific variable was
responsible for this effect.
In terms of weekday IWG, participant 3 showed a moderate reduction in IWG
(9.8%) of .4 kg (.88 lb.) during the brief introductory phase, which was followed by a
small increase (5.4% or .2 kg) during the monitoring phase (see Figure 3, lower graph).
The addition of the monetary reward contingency was associated with a moderate
reduction in IWG (10.3%) of .4 kg. These results were replicated and even stronger when
the reward was removed and again added during the final combination phase. During the
monitoring only phase there was a very large increase in IWG (31.4%) of 1.1 kg followed
by a moderate reduction in IWG (17.4%) of 1.9 kg (4.18 lb.) during the final combination
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phase. For this individual, the weekday IWG reductions during the combination phase,
and not the monitoring phase, were due to the effect of the monetary reward contingency.
Participant 4 – monetary reward contingency first. At the treatment program’s
conclusion, participant 4’s average weekend IWG was .8 kg (1.76 lb.) less than baseline
and his weekday IWG was .4 kg (.88 lb.) less than baseline (see Figure 4). For weekend
IWG, this individual demonstrated a small decrease (2.9% or .2 kg) during the brief
introductory phase followed by a moderate IWG increase (8.8%) of .6 kg (1.32 lb.)
during the monetary reward contingency phase (Figure 4, upper graph). The addition of
monitoring was associated with a moderate IWG reduction (9.5%) of .7 kg (1.54 lb.).
Return to the previous monetary reward-only condition was accompanied by a further,
small decrease (3% or .2 kg). The final combination phase was associated with an even
further, small weekend IWG decrease (4.6%) of .3 kg (.66 lb.). It must be noted,
however, that this participant never earned the reward offered so, in effect, the treatment
variable was never introduced. A tentative conclusion is that, for this participant,
monitoring fluid and diet intake was somewhat more effective in reducing weekend IWG
than were nonspecific factors such as attention and instructions about how to reduce fluid
intake.
During the weekday HD sessions, participant 4 maintained baseline IWG levels in
the brief introductory phase, followed by moderate IWG reductions (10.2%) of .5 kg (1.1
lb.) with the introduction of the monetary reward contingency (see Figure 4, lower
graph). However, it is again noted that this participant never received the monetary
reward. Following the addition of monitoring, a small increase in IWG (4.6% or .2 kg)
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was observed with a further small IWG increase (8.7%) of .4 kg (.88 lb.) when
monitoring was removed. The final combination phase was associated with a moderate
IWG reduction (10%) from an average IWG of 5.0 kg to 4.5 kg. As the reward variable
was never actually implemented, the monitoring variable may be compared only to
general, nonspecific aspects of the treatment that all participants received. Because
monitoring alone had inconsistent effects, there is no evidence that any treatment
component, alone or in combination, affected Participant 4’s weekday IWG.
Participant 5 – monetary reward contingency first. Participant 5 demonstrated an
average weekend IWG reduction of .7 kg (1.54 lb.) from baseline by the end of the study,
and an average weekday IWG reduction of 1.1 kg (2.42 lb.) from baseline (see Figure 5).
For weekends, a large IWG increase (18.2%) of .6 kg (1.32 lb.) was observed during the
introductory phase of the study (Figure 5, upper graph). This was followed by a moderate
IWG reduction (12.8%) of .5 kg, from baseline with the introduction of the monetary
reward contingency. The addition of monitoring during the combination phase was
associated with a further large IWG reduction (26.5%) from an average IWG of 3.4 kg to
2.9 kg. Subsequent removal of monitoring was associated with a very large increase in
IWG (32%) of .8 kg (1.76 lb.). This, again, was followed by a large weekend IWG
reduction (21.2%) during the final combination phase. Although there was a moderate
IWG reduction during the first reward-only phase, the IWG reductions were much larger
when monitoring was added to the treatment. This effect is supported by the observation
that when monitoring was removed from the combined treatment, the result was a very
large increase in weekend IWG. The effect of the combined treatment was replicated and,
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therefore, these results indicate that the .7 kg (1.54 lb.) reduction in average weekend
IWG at the end of treatment was associated with the combination of monitoring of fluid
and food intake and monetary reward.
Regarding weekday IWG, participant 5 demonstrated a large reduction in
weekday IWG (25.8%) or .8 kg (1.76 lb.) during the brief introductory phase of the study
(see Figure 5, lower graph). The introduction of the monetary reward contingency
resulted in a small increase in IWG (4.4% or .1 kg). The addition of monitoring was
associated with a small reduction in IWG (4.2%) or .1 kg (.22 lb.). A further, moderate
reduction in IWG (13%) or .3 kg (.66 lb.) resulted when monitoring was removed. The
final combination phase had no effect on weekday IWG beyond that of the reward alone;
no change in IWG was observed. Due to inconsistent results, the 1.1 kg reduction in
weekday IWG by the program’s end cannot be accounted for by any particular treatment
variable.
Participant 6 – monetary reward contingency first. By the end of the treatment
program, participant 6’s averaged weekend IWG was .2 kg (.44 lb.) less than baseline,
and her average weekday IWG was .1 kg (.22 lb.) less than baseline (see Figure 6). For
weekends, this individual demonstrated a very large IWG increase (38.2%) of 1.3 kg
(2.86 lb.) during the introductory phase (Figure 6, upper graph). The implementation of
the monetary reward contingency was associated with a large IWG reduction (25.5%),
from an average IWG of 4.7 kg to 3.5 kg. The addition of monitoring contributed nothing
to the effect of reward alone, and the lower IWG achieved in the prior phase was
maintained. A return to reward alone replicated previous results in that a further small
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reduction in IWG (8.6% or .3 kg) was observed. The final combination phase was
accompanied by a moderate increase in weekend IWG (12.5%) of .3 kg (.66 lb.).
In terms of weekday IWG, participant 6 showed a small reduction in weekday
IWG (7.7%) or .2 kg during the introductory phase (see Figure 6, lower graph).
Implementation of the monetary reward contingency was associated with a large increase
in weekday IWG (25%) or .6 kg (1.32 lb.)   The addition of monitoring was associated
with a very large IWG reduction (30%), from an average IWG of 3.0 kg to 2.1 kg.
Another small IWG reduction (9.5%), or .2 kg, was observed with the removal of
monitoring. This was followed by an unexpected, very large increase in weekday IWG
(31.6%) of .6 kg (1.32 lb.) in the final combination phase. Although participant 6’s
weekday IWG was 3.85% lower than baseline by the end of the program, a conclusion
cannot be made regarding the variable accountable for such an effect since the observed
IWG decrease associated with the combined treatment was not replicated.
In summary, two data sets (weekend and weekday IWG) were collected on each
of 6 participants. Of the 12 data sets, 4 showed some consistency of results across
repeated alternating conditions, and these were not the same for weekend and weekday
IWG data. For Participant 1, monitoring alone was always accompanied by reductions in
weekend IWG. Adding the monetary reward to monitoring was associated with reversal
of these reductions. For Participant 6, the monetary reward always was associated with
reductions in weekend IWG, whereas, the addition of monitoring either had no effect or
was accompanied by increases in weekend IWG.
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Two weekday data sets showed consistent results as well. Increases in weekday
IWG for Participant 2 were consistently observed when monitoring alone was in effect.
Adding the monetary reward to monitoring always was associated with reductions in
weekday IWG. Participant 3 showed a similar pattern of increases in weekday IWG
associated with monitoring alone and reductions in weekday IWG when the monetary
reward was added to monitoring. The remaining eight data sets were inconclusive
regarding systematic effects of either component alone or the two components in
combination.
Standardized Dry Weight Criterion
In addition to using a percentage of a participant’s dry weight as a selection
procedure, 3% and 4% of dry weight for weekday and weekend HD sessions,
respectively, were used to set treatment goals. Only 1 of the 6 participants (participant 6)
actually reached that goal, and it was for the weekday HD sessions. It is also noteworthy
that this participant was the least nonadherent of all the participants.
Discussion
The goal of this study was to begin dismantling a behavioral treatment package to
examine the individual and additive effects of two treatments included in previous
interventions for reducing IWG: monitoring and monetary reward contingency.
Furthermore, the study sought to assess the usefulness of standardized adherence criteria
based upon participants’ dry weights for setting treatment goals.
  Most of the 6 participants demonstrated behavior changes considered to positively
impact their health. However, although the 6 participants averaged a 14% reduction in
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weekday IWG by the end of the study as compared to baseline levels, and 4 out of 6
participants averaged a 15.45% reduction in weekend IWG, it cannot be concluded that
the independent variables were associated with any real effect due to the enormous
amount of variability found in the IWG data. Therefore, it is not possible to conclude if
any observed effects are real.
Results indicated that the treatment variables had different effects on weekend
and weekday IWG. Within-participant replication of treatment results showed that, for
one participant monitoring was effective and for another participant monetary reward was
effective for reducing weekend IWG. To the investigator’s knowledge, this is the first
time that such differential effects of treatment components have been observed for
weekend and weekday HD sessions. That either individual component was consistently
more effective on weekend IWG than the combined variables is clinically relevant, as it
would be unnecessary to subject patients to complex treatment packages if only one
component would effectively improve health behaviors. This is supportive of Finn and
Alcorn’s (1986) suggestion that the minimal interventions required to produce behavior
change should be examined and implemented. This is particularly true in the case of
monitoring, which adds no financial cost to treatment implementation.
Further inconsistencies between weekend and weekday IWG were observed.
While an increase in weekend IWG was accounted the information-gathering phase, a
reduction in weekday IWG was associated with this phase (see Table 1). The reason for
this difference is not evident, although most participants reported that it was easier to
exert control over weekday drinking behaviors, which would then make it somewhat
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easier to intervene with nonspecific treatment variables such as attention. That there were
few systematic effects of the treatment variables and that results generally were not
replicated implies that a variable held constant actually may have been the effective
factor for reducing IWG. Nonspecific factors such as establishing rapport, problem
solving, and/or gathering information (held constant here) may be more effective than
either monitoring or monetary reward alone, at least for weekday reductions for some
individuals.
An additional difference between weekend and weekday IWG was that during the
weekday HD sessions neither individual treatment variable, when initially introduced in
isolation, was as effective in reducing IWG as during the weekend HD sessions. It should
be noted that reductions in weekday IWG were observed during the rapport-establishing
phase, which does not rule out the possibility that nonspecific treatment effects were
associated with the decreases in weekday IWG.
It also must be noted that changing the treatment variables at arbitrary times (4
weeks per treatment phase) is inconsistent with standard behavioral research. Usually,
one would continue administering a treatment until the data or behavior stabilizes, then
implement a change in treatment. Such a procedure was not possible, considering the
contingencies (such as time constraints) under which the experimenter was operating.
Because treatment outcomes for nonadherence in HD patients are highly
individualized, the question of identifying what works for what patient warrants further
research. One explanation for the observation that monitoring is effective for some and
not for others is that some individuals may prefer to be unaware of their fluid intake
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(inclined toward “denial”). Indeed, some of the patients expressed dislike of monitoring
their fluid intake and did not want to think about their intake throughout the day.
However, other patients seemed to be quite interested in learning more about their own
behavior and assumed an “experimenter” role in finding the best strategies to control
fluid intake.
Why individual components would appear to be more effective for weekend IWG
and the combination treatment would tend to be more effective for weekday IWG is not
clear. This observation is counterintuitive, as participants agreed that controlling weekend
fluid intake was by far the most difficult aspect of their fluid regimen, due to the longer
period of time between HD sessions and the greater amount of control required.
Therefore, it would seem that a combination treatment package would be needed for
behavior change for weekend IWG. However, while results supporting this trend were
observed, they were not replicated across participants.
An additional goal of this study was to examine the usefulness of a standardized
criterion for fluid adherence, as suggested by several researchers (Manley & Sweeney,
1986; Sensky, 1993). Consistent with Keane, Prue, and Collins (1981), different criteria
were assigned for weekend and weekday IWG to account for differences in time interval
between HD weekday sessions and HD sessions following the weekend. Specifically,
both the selection of participants and the establishment of treatment goals were based
upon a proportion of each patient’s dry weight: 3% of their dry weight for weekday
sessions and 4% of their dry weight for weekend sessions, to allow for the extra day
between HD sessions. Use of these standard criteria for selection of nonadherent
44
participants, rather than use of arbitrary and varying criteria, would increase the internal
and external validity of outcome studies. However, using these criteria to set treatment
goals may not have been as beneficial as predicted because only one participant reached
the treatment goal. The exception was a participant who met the goal for weekday IWG
only. While it was expected to benefit larger patients who realistically could tolerate
higher weight gain, most of the participants were severe fluid overloaders, and exhibited
more severe overloading relative to many participants in other studies that reported
baseline IWG or daily weight gains. Therefore, it is possible that for these participants
treatment goals were set unreasonably high and were too difficult for them to attain. As
previously stated, one participant was so severely overloaded that no approximations of
the goal were ever achieved, and thus he never received the monetary reward. Clinicians
interested in a data-based approach might find a potential solution to this problem by
implementing a changing criterion while shaping the behavior necessary to reach a more
lenient criterion, as a first step toward reaching a final treatment goal.
Research and clinical work in this area is quite complex and difficult, in large
part, because of the highly individualized nature of nonadherence due to factors such as
differences in life circumstances, employment, and disease comorbidity. Lack of
replicable results and the differential effects observed between weekend and weekday
IWG may be the result of dissimilar weekend and weekday environments and associated
behavioral repertoires controlling fluid intake. For example, participants who were
employed noted that their fluid intake increased over the weekends because drinks were
more readily available and their activities were less structured.
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Another uncontrolled variable is a patient’s living situation, which may be more
or less conducive to behavior change. For one unemployed participant in the present
study, the prevailing reason given for nonadherence was the tempting presence of
abundant drinks and high-fluid content foods, as well as a self-perceived lack of control
over diet and food preparation. That the structure of a patient’s home environment can
influence adherence is consistent with the beneficial effect on IWG observed when
several participants were hospitalized during the study.
Diseases that often accompany ESRD, such as diabetes and hypertension, make
adherence and interventions additionally challenging. Two participants in the present
study had insulin-dependent diabetes, and both expressed frustrations with the fluid, diet
and medication requirements of ESRD that are in addition to requirements for controlling
diabetes, making the entire regimen seem overwhelming. This further emphasizes the
need for individualized interventions that incorporate shaping techniques to achieve long-
term goals.
Unwillingness to make behavior change is a major factor in nonadherence, and
interventions such as positive reinforcement may serve to enhance motivation for change.
Although some theoretical models address this problem and attempt to explain why
patients do not adhere to their medical regimen (e.g., Health Belief Model), HD patients
have a unique reason that may undermine intervention attempts - the possibility of kidney
transplantation. Three of the six participants in the present study were on the transplant
list and the other three participants were in the application process. A valid question for
any HD patient is, “why make difficult lifestyle changes and alter habits that have been
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present for most of my life if a very good possibility exists for a kidney transplant?”
While there are important reasons for making these changes, namely improved health
maintenance and quality of life, for many patients the long-term predicted benefits are not
worth the current effort.
A strength of the current study was the attempt to bolster internal validity, by
including extended pre-intervention baseline data to establish stability of nonadherent
behavior, controlling for the minimum length of HD treatment history, use of a
standardized criterion to select patients, and keeping nonspecific treatment variables
constant for all participants throughout the study. However, the differential effects of the
treatment variables for weekend and weekday IWG and the lack of replication of many of
the data sets reflect the effect of uncontrolled variables. Some of these variables have
already been mentioned (disease comorbidity, employment, hospitalizations, living
situations). Therefore, clinicians interested in a data-based approach with this population
must take into account these and other possibly uncontrollable variables.
In terms of clinical work, practitioners may have to take into consideration each
patient’s life circumstances and situations that prevent generalization of skills to different
situations and environments. Assessment of antecedents and consequences that vary
between weekdays and weekends should be considered for effective interventions and
deserves the attention of future research.
In summary, while most of the participants demonstrated improvements in IWG
the treatment variables responsible for the changes were not the same for all participants,
suggesting the need for more attention to specific patient characteristics and responsivity
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to particular treatment components. Furthermore, the variability in the data precludes the
possibility of stating equivocally that the changes in mean IWG were real. At this time, it
may be impossible to determine the single most important treatment variable associated
with adherence improvements in HD patients, but this very uncertainty provides an
interesting challenge for future research in this area.
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Table 1.
Differences in weekend and weekday average IWG (Kg) between baseline phase and final
treatment phase. Bolded, negative numbers indicate average reductions.
Participant
Weekend         Weekday
1      -.5     -.8
2      3.4     -.5
3    -1.4     -.3
4     -.8     -.4
5     -.7   -1.1
6      .2     -.1
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Table 2.
Descriptive statistics for interdialytic weight gains (IWG) of baseline and treatment phases for
participants in each condition.
Participant Weekend/Weekday (Kg)
                                                            Monitoring First
                         Baseline       Begin   Monitoring    M + $          M            M + $
        1: M         6.6/4.6         6.9/4.3      6.0/3.6       7.0/4.9      6.0/4.1       6.1/3.8
            Md       6.4/4.5         6.8/4.7      6.1/3.3       7.1/4.8      5.8/4.0       6.4/3.8
            SD       .97/.87         .17/1.15    .40/1.30     .28/.52      .74/1.52     1.0/.97
        2: M         6.2/4.2        7.7/4.3      8.1/4.4       7.3/4.3      8.9/5.6       9.6/3.7
            Md       5.8/4.4        7.7/4.2      7.7/4.6       7.0/3.7      9.1/4.8     10.0/3.2
            SD     1.65/1.05      1.0/1.43  1.22/1.98     .81/1.10    .62/1.56   1.10/.90
        3: M        6.5/4.1        7.4/3.7      4.8/3.9       5.5/3.5      6.8/4.6       5.1/3.8
            Md      6.4/3.9        7.4/3.0      4.5/3.8       5.3/3.5      6.1/4.7       5.3/3.4
            SD     1.09/.66      2.62/2.1     1.4/.36       .93/1.19  1.18/.79       .52/1.1
Monetary Reward First
   Baseline      Begin         $           M + $        $           M + $
          4. M          7.0/4.9       6.8/4.9    7.4/4.4      6.7/4.6       6.5/5.0        6.2/4.5
  Md       7.0/5.0        6.8/4.9    7.4/4.3      6.4/4.8       6.5/4.8        6.3/4.7
  SD       .63/.78        1.7/.55    .73/.53      1.1/.48     1.02/.91        .94/.56
          5. M        3.3/3.1         3.9/2.3    3.4/2.4      2.5/2.3        3.3/2.0        2.6/2.0
  Md      3.2/3.4         3.9/2.3    3.3/2.4      2.5/2.3        3.1/2.0        2.6/2.0
  SD      .60/1.13       .71/.34    .55/1.2      .26/.48        .57/.63        .37/.78
          6. M       3.4/2.6         4.7/2.4    3.5/3.0      3.5/2.1        3.2/1.9        3.6/2.5
  Md     3.4/2.8         4.7/2.6    3.6/3.0      3.2/2.3        3.2/2.0        3.5/2.4
  SD     .98/.91         .42/.38  1.16/.68      1.7/1.1        .30/.60        .49/.43
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Table 3.
Percent change statistics of mean interdialytic weight gain (IWG) per phase. Bolded, negative




Rapport   M      M+$       M       M+$ Rapport   M        M+$       M        M+$
1 4.5% -13% 16.7%  -14.3%    1.7% -6.5%  -16.3%   36.1%  -16.3%  -7.3%
2 24.2%  5.2% -9.9%   22.9%    7.9% 2.4%   2.3%    -2.3%   30.2%   -33.9%
3 13.9%  -35.1% 14.6%  23.6%   -25% -9.8%   5.4%    -10.3%  31.4%   -17.4%
Reward First
Weekend Weekday
Rapport   $         $+M       $         $+M Rapport    $          $+M       $          $+M
4 -2.9%  8.8%   -9.5%    -3%      -4.6% 0%      -10.2%      4.6%     8.7%     -10%
5 18.2% -12.8%  -26.5%  32%    -21.2% -25.8%  4.4%     -4.2%    -13%       0%



















































Figure 1. Participant 1's weekend and weekday weight gains since previous dialysis session (IWG).  





























































Figure 2. Participant 2's weekend and weekday weight gains since previous dialysis session  (IWG).  











































































Figure 3. Participant 3's weekend and weekday weight gains since previous dialysis session (IWG).  


































































Figure 4. Participant 4's weekend and weekday weight gains since previous
dialysis session (IWG).  Dotted lines indicate target IWG.  Bold dashed lines 





































   
in Participant 5 Weekdays
Figure 5.  Participant 5's weekend and weekday weight gains since previous session 
(IWG).  Dotted lines indicate target IWG.  Bold dashed lines indicate mean IWG for 





















































































Figure 6. Participant 6's weekend and weekday weight gains since previous dialysis session (IWG).  
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